[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"q-nurse-113-3-basic-medicine-036":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":24},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":23},"nurse-113-3-基礎醫學-036","nurse-113-3-basic-medicine-036",113,3,36,"下列藥物中，何者為抗凝血劑（anticoagulant），主要用於預防深層靜脈栓塞（deep vein thrombosis）生成？",{"A":15,"B":16,"C":17,"D":18},"clopidogrel","tirofiban","aspirin","rivaroxaban","D",null,[],"本題考點在於區分「抗凝血劑」與「抗血小板藥」兩大類抗栓塞藥物。深層靜脈栓塞屬於靜脈系統血流緩慢形成的纖維蛋白血栓，主力靠凝血瀑布，故預防用藥為抗凝血劑。依作用機轉，rivaroxaban 直接抑制凝血因子 Xa，阻斷凝血酶生成，正是預防與治療深層靜脈栓塞的口服抗凝血劑，選 D。其餘三者皆屬抗血小板藥，主要用於動脈血栓（如冠心症、腦中風）：clopidogrel 為 P2Y12 受體阻斷劑，抑制 ADP 活化血小板；tirofiban 為 GPIIb\u002FIIIa 受體拮抗劑，阻斷血小板聚集最後共同途徑；aspirin 抑制 COX-1、減少血栓素 A2。三者作用在血小板而非凝血因子，對靜脈栓塞預防非首選。",1,[25,29,33,36,40,44],{"webId":26,"stem":27,"number":23,"year":28,"session":23},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",106,{"webId":30,"stem":31,"number":32,"year":28,"session":23},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":34,"stem":35,"number":11,"year":28,"session":23},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",{"webId":37,"stem":38,"number":39,"year":28,"session":23},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":41,"stem":42,"number":43,"year":28,"session":23},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":45,"stem":46,"number":47,"year":28,"session":23},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840771642]